$AGIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AGIOS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AGIOS PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.10 | 35,447 | 1,776,026 | 1,650 | 37.1 K to 1.7 K (-95.55 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 35,447 | 1,246,317 | 37,097 | 1.7 K to 37.1 K (+2,148.30 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.03 | 14,191 | 709,963 | 1,650 | 15.8 K to 1.7 K (-89.58 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 8,526 | 299,774 | 15,841 | 7.3 K to 15.8 K (+116.56 %) |
Jan 08 2020 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Option Exercise | A | 0.00 | 10,311 | 0 | 10,311 | |
Jan 08 2020 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Option Exercise | A | 48.49 | 47,007 | 2,279,369 | 47,007 | |
Dec 30 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 50.09 | 2,950 | 147,766 | 184 | 3.1 K to 184 (-94.13 %) |
Dec 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Jonathan | Chief Legal Officer | Option Exercise | A | 0.00 | 17,259 | 0 | 17,259 | |
Dec 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Jonathan | Chief Legal Officer | Option Exercise | A | 39.11 | 78,824 | 3,082,807 | 78,824 | |
Nov 15 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | P | 31.00 | 40,322 | 1,249,982 | 41,722 | 1.4 K to 41.7 K (+2,880.14 %) |
Nov 15 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | P | 31.00 | 8,064 | 249,984 | 97,567 | 89.5 K to 97.6 K (+9.01 %) |
Nov 14 2019 | AGIO | AGIOS PHARMACEUTIC ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 31.00 | 403,225 | 12,499,975 | 1,777,824 | 1.4 M to 1.8 M (+29.33 %) |
Jun 14 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Gift | G | 0.00 | 5,000 | 0 | 32,609 | 37.6 K to 32.6 K (-13.29 %) |
Jun 13 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 2.34 | 7,218 | 16,872 | 0 | |
Jun 13 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 2.34 | 7,218 | 16,872 | 33,729 | 26.5 K to 33.7 K (+27.23 %) |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 0.00 | 1,878 | 0 | 1,878 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 47.91 | 8,919 | 427,309 | 8,919 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Buy | M | 0.00 | 1,400 | 0 | 1,971 | 571 to 2 K (+245.18 %) |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 0.00 | 1,878 | 0 | 1,878 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 47.91 | 8,919 | 427,309 | 8,919 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | M | 0.00 | 1,400 | 0 | 37,609 | 36.2 K to 37.6 K (+3.87 %) |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 0.00 | 1,878 | 0 | 1,878 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 47.91 | 8,919 | 427,309 | 8,919 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Buy | M | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 0.00 | 1,878 | 0 | 1,878 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 47.91 | 8,919 | 427,309 | 8,919 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 0.00 | 1,400 | 0 | 3,600 | 2.2 K to 3.6 K (+63.64 %) |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 0.00 | 1,878 | 0 | 1,878 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 47.91 | 8,919 | 427,309 | 8,919 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Buy | M | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
Apr 24 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 17,678 | 0 | 17,678 | |
Apr 09 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 39.76 | 3,000 | 119,280 | 39,648 | |
Apr 09 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 68.12 | 599 | 40,804 | 26,511 | 27.1 K to 26.5 K (-2.21 %) |
Apr 09 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 67.61 | 2,401 | 162,332 | 27,110 | 29.5 K to 27.1 K (-8.14 %) |
Apr 09 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 39.76 | 3,000 | 119,280 | 29,511 | 26.5 K to 29.5 K (+11.32 %) |
Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 10,000 | 351,600 | 71,000 | |
Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 68.72 | 100 | 6,872 | 7,238 | 7.3 K to 7.2 K (-1.36 %) |
Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 68.09 | 1,500 | 102,135 | 7,338 | 8.8 K to 7.3 K (-16.97 %) |
Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 66.85 | 2,546 | 170,200 | 8,838 | 11.4 K to 8.8 K (-22.36 %) |
Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 66.03 | 5,854 | 386,540 | 11,384 | 17.2 K to 11.4 K (-33.96 %) |
Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 10,000 | 351,600 | 17,238 | 7.2 K to 17.2 K (+138.16 %) |
Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 10,000 | 351,600 | 81,000 | |
Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 64.64 | 1,300 | 84,032 | 7,238 | 8.5 K to 7.2 K (-15.23 %) |
Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 64.09 | 8,700 | 557,583 | 8,538 | 17.2 K to 8.5 K (-50.47 %) |
Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 10,000 | 351,600 | 17,238 | 7.2 K to 17.2 K (+138.16 %) |
Mar 07 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 39.76 | 2,572 | 102,263 | 42,648 | |
Mar 07 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 428 | 13,542 | 11,354 | |
Mar 07 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 68.22 | 200 | 13,644 | 26,511 | 26.7 K to 26.5 K (-0.75 %) |
Mar 07 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 67.73 | 2,600 | 176,098 | 26,711 | 29.3 K to 26.7 K (-8.87 %) |
Mar 07 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 66.45 | 200 | 13,290 | 29,311 | 29.5 K to 29.3 K (-0.68 %) |
Mar 07 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 39.76 | 2,572 | 102,263 | 29,511 | 26.9 K to 29.5 K (+9.55 %) |
Mar 07 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 428 | 13,542 | 26,939 | 26.5 K to 26.9 K (+1.61 %) |
Mar 01 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 3,080 | 97,451 | 11,782 | |
Mar 01 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 4,154 | 37,594 | 0 | |
Mar 01 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 1,766 | 830 | 0 | |
Mar 01 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 9,000 | 585,000 | 26,511 | 35.5 K to 26.5 K (-25.34 %) |
Mar 01 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 3,080 | 97,451 | 35,511 | 32.4 K to 35.5 K (+9.50 %) |
Mar 01 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 4,154 | 37,594 | 32,431 | 28.3 K to 32.4 K (+14.69 %) |
Mar 01 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 1,766 | 830 | 28,277 | 26.5 K to 28.3 K (+6.66 %) |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 58.86 | 40,000 | 2,354,400 | 40,000 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 58.86 | 40,000 | 2,354,400 | 40,000 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 2,074 | 0 | 2,074 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 58.86 | 8,295 | 488,244 | 8,295 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 0.00 | 8,324 | 0 | 8,324 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 58.86 | 45,719 | 2,691,020 | 45,719 | |
Feb 25 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 3,300 | 0 | 0 | |
Feb 25 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 56.33 | 1,016 | 57,231 | 2,796 | 3.8 K to 2.8 K (-26.65 %) |
Feb 25 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 3,300 | 0 | 3,812 | 512 to 3.8 K (+644.53 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 8,125 | 0 | 16,250 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 58.03 | 2,471 | 143,392 | 89,503 | 92 K to 89.5 K (-2.69 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 8,125 | 0 | 91,974 | 83.8 K to 92 K (+9.69 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Payment of Exercise | F | 58.03 | 1,040 | 60,351 | 10,941 | 12 K to 10.9 K (-8.68 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 0.00 | 2,750 | 0 | 11,981 | 9.2 K to 12 K (+29.79 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 58.03 | 821 | 47,643 | 12,374 | 13.2 K to 12.4 K (-6.22 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 2,750 | 0 | 13,195 | 10.4 K to 13.2 K (+26.33 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 58.03 | 818 | 47,469 | 7,195 | 8 K to 7.2 K (-10.21 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 8,013 | 5.3 K to 8 K (+52.25 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Payment of Exercise | F | 58.03 | 876 | 50,834 | 26,511 | 27.4 K to 26.5 K (-3.20 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.00 | 2,750 | 0 | 27,387 | 24.6 K to 27.4 K (+11.16 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 790 | 0 | 1,580 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 58.03 | 278 | 16,132 | 512 | 790 to 512 (-35.19 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 790 | 0 | 790 | 0 to 790 |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 76.45 | 152 | 11,620 | 0 | 152 to 0 (-100.00 %) |
Feb 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 42,695 | 0 | 42,695 | |
Feb 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 53.87 | 350,346 | 18,873,139 | 350,346 | |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 52.82 | 4,555 | 240,595 | 10,445 | 15 K to 10.4 K (-30.37 %) |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Payment of Exercise | F | 52.82 | 5,769 | 304,719 | 9,231 | 15 K to 9.2 K (-38.46 %) |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 6,265 | 0 | 0 | |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 52.82 | 1,960 | 103,527 | 5,229 | 7.2 K to 5.2 K (-27.26 %) |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 6,265 | 0 | 7,189 | 924 to 7.2 K (+678.03 %) |
Dec 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 2.34 | 20,500 | 47,919 | 7,218 | |
Dec 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 2.34 | 20,500 | 47,919 | 7,218 | |
Dec 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 2.34 | 20,500 | 47,919 | 24,637 | 4.1 K to 24.6 K (+495.53 %) |
Dec 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 2.34 | 20,500 | 47,919 | 24,637 | 4.1 K to 24.6 K (+495.53 %) |
Nov 19 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Gift | G | 0.00 | 1,000 | 0 | 270,772 | 271.8 K to 270.8 K (-0.37 %) |
Nov 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 4,154 | |
Nov 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 71.42 | 100 | 7,142 | 50,932 | 51 K to 50.9 K (-0.20 %) |
Nov 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 70.23 | 700 | 49,161 | 51,032 | 51.7 K to 51 K (-1.35 %) |
Nov 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 69.44 | 2,200 | 152,768 | 51,732 | 53.9 K to 51.7 K (-4.08 %) |
Nov 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 53,932 | 50.9 K to 53.9 K (+5.89 %) |
Oct 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 7,154 | |
Oct 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 71.77 | 21 | 1,507 | 50,932 | 51 K to 50.9 K (-0.04 %) |
Oct 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 71.05 | 1,100 | 78,155 | 50,953 | 52.1 K to 51 K (-2.11 %) |
Oct 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 69.47 | 979 | 68,011 | 52,053 | 53 K to 52.1 K (-1.85 %) |
Oct 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 68.56 | 900 | 61,704 | 53,032 | 53.9 K to 53 K (-1.67 %) |
Oct 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 53,932 | 50.9 K to 53.9 K (+5.89 %) |
Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 71.74 | 14,162 | 1,015,982 | 22,047 | 36.2 K to 22 K (-39.11 %) |
Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 73.82 | 2,400 | 177,168 | 36,209 | 38.6 K to 36.2 K (-6.22 %) |
Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 72.52 | 11,155 | 808,961 | 38,609 | 49.8 K to 38.6 K (-22.42 %) |
Sep 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 31.64 | 8,730 | 276,217 | 137,471 | |
Sep 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 31.64 | 8,730 | 276,217 | 83,849 | 75.1 K to 83.8 K (+11.62 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 31.64 | 2,500 | 79,100 | 146,201 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 2.34 | 72,619 | 169,928 | 0 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 31.64 | 2,500 | 79,100 | 75,119 | 72.6 K to 75.1 K (+3.44 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 2.34 | 72,619 | 169,928 | 72,619 | 0 to 72.6 K |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 52.29 | 312 | 16,314 | 12,266 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 83.00 | 312 | 25,896 | 152 | 464 to 152 (-67.24 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 52.29 | 312 | 16,314 | 464 | 152 to 464 (+205.26 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 10,154 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 84.38 | 100 | 8,438 | 57,196 | 57.3 K to 57.2 K (-0.17 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 83.17 | 2,260 | 187,964 | 57,296 | 59.6 K to 57.3 K (-3.79 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 82.52 | 640 | 52,813 | 59,556 | 60.2 K to 59.6 K (-1.06 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 1,700 | 59,772 | 91,000 | |
Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 300 | 10,548 | 92,700 | |
Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 80.03 | 1,700 | 136,051 | 924 | 2.6 K to 924 (-64.79 %) |
Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 1,700 | 59,772 | 2,624 | 924 to 2.6 K (+183.98 %) |
Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 80.00 | 300 | 24,000 | 924 | 1.2 K to 924 (-24.51 %) |
Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 300 | 10,548 | 1,224 | 924 to 1.2 K (+32.47 %) |
Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 60,650 | |
Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 74.92 | 2,050 | 153,586 | 0 | 2.1 K to 0 (-100.00 %) |
Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Aug 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 13,154 |